P3 Health Partners director granted 2,000 RSUs

P3 Health Partners Inc. director reported an equity grant and corrected prior share ownership figures.

Rhea-AI Filing Summary

P3 Health Partners Inc. director reported an equity grant and corrected prior share ownership figures. On 08/06/2025, the director received 2,000 restricted stock units (RSUs) of Class A common stock at a price of $0 under the company’s 2021 Incentive Award Plan. Each RSU represents one share of Class A common stock and will vest upon the earlier of the company’s 2026 annual stockholder meeting and the one-year anniversary of the grant date.

Following the update, the director is shown as beneficially owning 6,331 shares of Class A common stock directly. The amendment was filed to correct the number of securities beneficially owned after the company’s 1-for-50 reverse stock split, which became effective on April 11, 2025, and is limited to fixing that post-split share count.

Insider Trade Summary

Grant/Award: 2,000 shares

Grant/Award 1 txn

Insider Park Jeffrey G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	2,000	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 6,331 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date.
2. F2. This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did P3 Health Partners Inc. (PIII) report in this Form 4/A?

The filing reports a grant of 2,000 restricted stock units (RSUs) of Class A common stock to a director of P3 Health Partners Inc. on 08/06/2025 at a price of $0.

How do the RSUs granted to the PIII director vest?

The 2,000 RSUs vest upon the earlier of P3 Health Partners Inc.’s 2026 annual stockholder meeting and the one-year anniversary of the 08/06/2025 grant date. Each RSU converts into one share of Class A common stock upon vesting.

How many P3 Health Partners (PIII) shares does the director beneficially own after this transaction?

After the reported transaction and correction, the director is shown as beneficially owning 6,331 shares of Class A common stock directly.

Why was this P3 Health Partners (PIII) Form 4/A filed as an amendment?

The amendment was filed to correct Column 5 of Table I, which had inadvertently reported the director’s beneficial ownership before the company’s 1-for-50 reverse stock split. It updates the share count to reflect ownership after the reverse stock split.

What reverse stock split did P3 Health Partners Inc. (PIII) complete that affected this Form 4/A?

P3 Health Partners Inc. completed a 1-for-50 reverse stock split that became effective on April 11, 2025. The amended filing corrects the director’s post-split beneficial ownership to align with this adjustment.

What role does the reporting person hold at P3 Health Partners Inc. (PIII)?

The reporting person is identified as a Director of P3 Health Partners Inc. and holds the 6,331 Class A common shares in direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 06:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Park Jeffrey G

(Last) (First) (Middle)

C/O P3 HEALTH PARTNERS INC.

2370 CORPORATE CIRCLE, SUITE 300

(Street)

HENDERSON NV 89074

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
P3 Health Partners Inc. [ PIII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/08/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/06/2025		A		2,000(1)	A	$0	6,331(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date.

2. This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split.

Remarks:

	/s/Todd Smith, Chief Legal Officer, as attorney-in-fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.